Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome

AR Cardones - Clinics in Dermatology, 2020 - Elsevier
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a severe
cutaneous drug reaction characterized by fever, lymphadenopathy, hematologic …

Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and …

BM Wei, LP Fox, BH Kaffenberger, AM Korman… - Journal of the American …, 2023 - Elsevier
Drug-induced hypersensitivity syndrome (DiHS), also known as drug reaction with
eosinophilia and systemic symptoms (DRESS), is a severe cutaneous adverse reaction …

Drug reaction with eosinophilia and systemic symptoms (DRESS): series of 49 French pediatric cases

E Bedouelle, BB Said, F Tetart, B Milpied… - The Journal of Allergy …, 2022 - Elsevier
Background Drug reaction with eosinophilia and systemic symptoms (DRESS) is a rare and
potentially fatal adverse reaction. It can be difficult to diagnose, even more so among …

Evaluation of cyclosporine for the treatment of DRESS syndrome

E Nguyen, D Yanes, S Imadojemu… - JAMA …, 2020 - jamanetwork.com
Discussion| Our study findings suggest that the superior efficacy of PDL treatment of PWSs
located proximally on the limb might be associated with the more superficial distribution of …

[HTML][HTML] Advances in understanding of the pathogenesis and therapeutic implications of drug reaction with eosinophilia and systemic symptoms: an updated review

CB Chen, WK Hung, CW Wang, CC Lee… - Frontiers in …, 2023 - frontiersin.org
Drug reaction with eosinophilia and systemic symptoms or drug-induced hypersensitivity
syndrome (DRESS/DIHS) is one type of severe cutaneous adverse reaction (SCAR). It is …

[HTML][HTML] Mechanism of lethal skin toxicities induced by epidermal growth factor receptor inhibitors and related treatment strategies

Y Li, R Fu, T Jiang, D Duan, Y Wu, C Li, Z Li… - Frontiers in …, 2022 - frontiersin.org
Epidermal growth factor receptor (EGFR) inhibitors are widely used to treat various types of
cancers such as non-small cell lung cancer, head and neck cancer, breast cancer …

[HTML][HTML] Tools to improve the diagnosis and management of T-cell mediated adverse drug reactions

AM Copaescu, M Ben-Shoshan, JA Trubiano - Frontiers in Medicine, 2022 - frontiersin.org
Delayed drug T-cell immune-mediated hypersensitivity reactions have a large clinical
heterogeneity varying from mild maculopapular exanthema (MPE) to severe cutaneous …

Cyclosporine as an alternative immunosuppressant for steroid-resistant drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome

K Tan, A Testro - BMJ Case Reports CP, 2023 - casereports.bmj.com
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a multiorgan
reaction associated with a broad range of commonly used medications. Most cases of …

[HTML][HTML] Drug reaction with eosinophilia and systemic symptoms syndrome

KC Shanoj, S Joseph, P Shenoy - Indian Journal of Rheumatology, 2019 - journals.lww.com
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a delayed
form of severe cutaneous adverse reaction (SCAR) seen in association with certain drugs …

Annular drug eruptions

WH Wu, CY Chu - Clinics in Dermatology, 2022 - Elsevier
Cutaneous adverse drug reactions are undesirable cutaneous changes caused by
medications. Drug eruptions can mimic a wide range of dermatoses that include …